Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
British Columbia Cancer Agency National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00632190 |
RATIONALE: New diagnostic procedures, such as spectroscopy, may be a less invasive way to check for dysplasia and neoplasia in the cervix. Spectroscopy may also used as a screening test to help doctors find cervical cancer sooner, when it may be easier to treat.
PURPOSE: This clinical trial is studying how well spectroscopy works in diagnosing dysplasia and neoplasia in the cervix in women undergoing colposcopy or Pap testing.
Condition | Intervention |
---|---|
Cervical Cancer Precancerous/Nonmalignant Condition |
Other: fluorophotometry Procedure: colposcopic biopsy Procedure: colposcopy Procedure: light-scattering spectroscopy |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label |
Official Title: | Measurement of Fluorescence EEM of Cervical Intraepithelial Neoplasia |
Estimated Enrollment: | 1800 |
Study Start Date: | January 2000 |
Primary Completion Date: | March 2003 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: This is a multicenter study. Patients are stratified according to menopausal status and current treatment (premenopausal not on oral contraceptive pills [OCP] vs premenopausal on OCP vs postmenopausal not on hormone replacement therapy [HRT] vs postmenopausal on HRT).
PROJECTED ACCRUAL: A total of 800 patients with abnormal Papanicolaou smears and 1000 subjects with normal Papanicolaou smears are accrued for this study.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Study ID Numbers: | CDR0000581311, BCCR-C99-0441, C99-0441 |
Study First Received: | March 7, 2008 |
Last Updated: | June 27, 2009 |
ClinicalTrials.gov Identifier: | NCT00632190 History of Changes |
Health Authority: | United States: Federal Government |
cervical cancer cervical intraepithelial neoplasia grade 1 cervical intraepithelial neoplasia grade 2 cervical intraepithelial neoplasia grade 3 |
Precancerous Conditions Carcinoma in Situ Neoplasms, Glandular and Epithelial Carcinoma Cervical Intraepithelial Neoplasia |
Neoplasms Neoplasms by Histologic Type Precancerous Conditions Carcinoma in Situ |
Neoplasms, Glandular and Epithelial Carcinoma Cervical Intraepithelial Neoplasia |